Skip to main content

Gains in tuberculosis control threatened by drug resistance (downtoearth,)

Gains made in controlling tuberculosis (TB) are now threatened by growing drug-resistance in the bacteria that causes it. Experts from various countries including India, China and South Africa expressed their concern in an article published in the journal Lancet Respiratory Medicine, on March 23.

They opine that the rise and spread of two kinds of drug resistant TB—multi-drug resistant (MDR) and extremely drug resistant (XDR) tuberculosis—mirrors the spread of antimicrobial resistance against malaria, HIV and gram negative pathogens. It is believed that drug resistant-TB resulted out of poor compliance of treatment regimens and programmatic failure is now being questioned.

The multi-drug resistant variant of TB remains unaffected by two of the most powerful anti-TB drugs, isoniazid and rifampicin. XDR-TB, is a form of drug-resistant TB with additional resistance to more anti-TB drugs that therefore responds to even fewer available medicines. XDR-TB involves resistance to isoniazid and rifampicin, another family of drugs called fluoroquinolones, and at least one of the three injectable second-line drugs.

The authors say that sub-optimal drug delivery may be one of the reasons for increase in drug resistant TB. To overturn this, the authors stress on new and repurposed drugs (such as bedaquiline) and updated policies.

Another article published in the same journal says that the TB-causing pathogen Mycobacterium tuberculosis had a 50-year head start in developing resistance to the current first line of treatment. It also points to the lack of commitment to address drug-resistant TB, which can now be a transmitted from one person to another. The authors propose that over the next decade, drug-resistant TB can spread in an unprecedented scale. Thus, its addressal will require a stronger commitment from high-burden countries, the article adds.

India is a hub for TB and its drug-resistant variants, according to the World Health Organization (WHO). The Global Tuberculosis Report 2016 reveals that India has been underreporting TB incidence by a large margin. The Union health ministry aims to eradicate the disease by 2025, but that cannot be done without addressing drug-resistance.

Labels:

Comments

Post a Comment

Popular posts from this blog

What's ailing Namami Gange programme?(DTE)

Winters are extremely hectic for Sushma Patel, a vegetable grower in Uttar Pradesh’s Chunar town. Her farm is in the fertile plains of Ganga where people grow three crops a year. But this is the only season when she can grow vegetables. And before that, she needs to manually dig out shreds of plastic and wrappers from her one-hectare (ha) farm. “This is all because of the nullah,” she says, pointing at an open drain that runs through her field, carrying sewage from the neighbourhood to the Ganga. “Every monsoon, the drain overflows and inundates the field with a thick, black sludge and plastic debris. We cannot even go near the field as the stench of sewage fills the air,” she says. But Patel has no one to complain to as this is the way of life for most people in this ancient town. About 70 per cent of the people in Chunar depend on toilets that have on-site sanitation, such as septic tanks and pits. In the absence of a proper disposal or management system, people simply dump the faec...
3 comments
Click Here To Read more »

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo...
2 comments
Click Here To Read more »

"ISRO has capabilities to build geostationary satellites for air quality monitoring” (downtoearth)

Pawan Gupta's findings on trans-boundary movement of pollution (Punjab to Delhi) from biomass burning in 2015 spurred debates. He participated in discussions with Indian regulators early September at the Better Air Quality Conference in Busan on the advantages of using satellite data for air quality monitoring. He explains to Down to Earth how air quality monitoring is done using satellite data. How is satellite data used to measure air pollution? Satellites that provide information on atmospheric pollutants are normally (not always) in the low earth orbits (400-1000 km above the Earth’s surface). A single satellite can carry one or more remote sensing instruments onboard that look down to earth and obtain information about the object in the field of view of satellite sensor. The Earth receives electromagnetic radiation from the sun, which travels through space and reaches the earth-atmosphere system. The radiation then interacts with the Earth’s atmosphere and the surface...
1 comment
Click Here To Read more »